Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Asian Spine Journal|February 24, 2015
A Prospective Randomized Clinical Trial Comparing Bone Union Rate Following Anterior Cervical Discectomy and Fusion Using a Polyetheretherketone Cage: Hydroxyapatite/B-Tricalcium Phosphate Mixture versus Hydroxyapatite/Demineralized Bone Matrix MixtureJemin Yi, Gun Woo Lee, Woo Dong Nam, et al.
Biochemical and Biophysical Research Communications|September 5, 2002
Inhibition of NF-kappaB activation by merlinJae Young Kim, Hongtae Kim, Sin-Soo Jeun, et al.
Frontiers in Cellular Neuroscience|May 10, 2018
Inhibition of GluR Current in Microvilli of Sensory Neurons via Na<sup>+</sup>-Microdomain Coupling Among GluR, HCN Channel, and Na<sup>+</sup>/K<sup>+</sup> PumpYasuhiro Kawasaki, Mitsuru Saito, Jonghwa Won, et al.
The Oncologist|June 6, 2019
A First-in-Human Phase I Study of GC1118, a Novel Anti-Epidermal Growth Factor Receptor Antibody, in Patients with Advanced Solid TumorsDo-Youn Oh, Keun-Wook Lee, Sae-Won Han, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2009
Oral administration of 1,4-aryl-2-mercaptoimidazole inhibits T-cell proliferation and reduces clinical severity in the murine experimental autoimmune encephalomyelitis modelEun Joo Jung, Minkyu Hur, Young Lim Kim, et al.
Science Advances|February 1, 2021
B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8<sup>+</sup> tumor-infiltrating lymphocytesGihoon You, Yangsoon Lee, Yeon-Woo Kang, et al.
Journal for Immunotherapy of Cancer|July 7, 2021
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockadeSeongju Jeong, Eunyoung Park, Hyung-Don Kim, et al.
Molecular Cancer Therapeutics|November 21, 2015
GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR LigandsYangmi Lim, Jiho Yoo, Min-Soo Kim, et al.
Molecular Cancer|June 5, 2014
Colon cancer-derived oncogenic EGFR G724S mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximabJeonghee Cho, Adam J Bass, Michael S Lawrence, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 8, 2022
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activationEunsil Sung, Minkyung Ko, Ju-Young Won, et al.
Pageof 4